139 related articles for article (PubMed ID: 7772736)
1. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
[TBL] [Abstract][Full Text] [Related]
2. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
3. C-erbB-2: expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
Anticancer Res; 1996; 16(2):765-71. PubMed ID: 8687126
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index.
Alexiev BA; Bassarova AV; Popovska SL; Popov AA; Christov CZ
Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249
[TBL] [Abstract][Full Text] [Related]
7. A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients.
Niewiadomska H; Mirowski M; Stempien M; Olborski B; Blonski JZ; Hanausek M; Wierzbicki R
Neoplasma; 1998; 45(4):216-22. PubMed ID: 9890664
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67 and p27(Kip1) in fine-needle aspirates from breast carcinoma and benign breast diseases.
Ramljak V; Sučić M; Vrdoljak DV; Borojević N
Diagn Cytopathol; 2011 May; 39(5):333-40. PubMed ID: 21488176
[TBL] [Abstract][Full Text] [Related]
10. [Expression of glucose transporter 1 in human breast carcinoma and its clinical significance].
Hao LS; Ni Q; Jia GQ; Wang G; Qian K; Liu YJ; Zhang Y; Wu XT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):44-7. PubMed ID: 19292042
[TBL] [Abstract][Full Text] [Related]
11. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method.
Alexiev BA
Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580
[TBL] [Abstract][Full Text] [Related]
12. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
13. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
14. The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma.
Niewiadomska H; Jeziorski A; Olborski B
J Exp Clin Cancer Res; 1998 Dec; 17(4):503-10. PubMed ID: 10089075
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen immunostaining in breast carcinoma and its relationship to clinical and pathological variables.
Agarwal S; Jain R; Rusia U; Gupta RL
Indian J Pathol Microbiol; 1997 Jan; 40(1):11-6. PubMed ID: 9145605
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
18. The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast.
Jeziorski A; Blonski JZ; Niewiadomska H
J Exp Clin Cancer Res; 2000 Mar; 19(1):61-7. PubMed ID: 10840938
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma.
Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D
APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
